Business Wire

Giga Carbon Neutrality (GCN) Signs Memorandum of Understanding to Acquire a Controlling Stake in Admiral Corporation of America Inc.

27.4.2022 14:29:00 EEST | Business Wire | Press release

Share

Giga Carbon Neutrality Inc (“GCN”), the intelligent commercial mobility and clean energy technology company, today announced that it has signed a Memorandum of Understanding to acquire a majority stake in Admiral Corporation of America Inc (“Admiral”) and subsidiary companies. Admiral, first established as Transformer Corporation of America in 1924, then re-established and re-branded in 1934 by founder Ross Siragusa, in its nearly 100-year history has been a global leader in home appliances and electronics. As it joins the GCN group of companies, Admiral is diversifying into the fast-growing sustainability business providing solutions in e-mobility, charging and energy storage.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005549/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

GCN’s fleet of zero carbon vehicles (Photo: Business Wire)

Upon completion of the acquisition, GCN will integrate its new energy mobility solutions – both battery and hydrogen powered logistics vehicles, specialist vehicles and buses – and mobile and stationary energy storage capabilities with Admiral subsidiary Admiral America Energy Inc (“AAE”).

Richard Martin, CEO at Giga Carbon Neutrality, commented:
This agreement brings the historic and well-loved Admiral brand into the GCN family. We are excited to avail ourselves of the opportunity of associating the trusted Admiral name with GCN’s worldwide mission of reducing carbon emissions through its full range of new energy vehicles.

About Giga Carbon Neutrality (www.gigacarbonneutrality.com)
Giga Carbon Neutrality is a clean energy trucking and technology company that makes running clean, reliable vehicle fleets easy for industrial and commercial transportation companies. GCN'S portfolio includes battery-electric and hydrogen fuel cell vehicles and marine vessels and clean energy storage, charging and refueling infrastructure support.

About Admiral ( www.admiral-america.com), (www.admiral.energy)
Admirals foray into Electrical Appliances commenced in 1934. Admiral received “Excellence” award from the U.S. government for its production efforts during the second world war in April 1944. The tagline for the brand was “Admiral first”. Admiral America Energy Inc envisions a new journey with Battery Electric Vehicle (BEV) and Fuel Cell Electric Vehicle (FCEV) to provide multiple clean energy solutions in electric, hydrogen fuel cell & methanol for a comprehensive ecosystem in clean energy commercial transportation.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information:
Giga Carbon Neutrality
press@gigacarbonneutrality.com

Admiral
Abby Thomas, +1 425 559 1602
abby@admiral-america.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 17:13:00 EEST | Press release

For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and more practical: what it takes to make a specific, high-stakes determination reliable, fast and affordable at scale. A vertical, domain-focused process, gro

Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 17:08:00 EEST | Press release

Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 17:00:00 EEST | Press release

Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by market capitalization and is home to world-leading companies such as Samsung Electr

Andersen Global Adds Depth to Tax and Global Mobility Capabilities in Germany30.6.2026 16:30:00 EEST | Press release

Andersen Global strengthens its presence through a Collaboration Agreement with Lohr and Company (L+C), a senior-led tax advisory platform, providing practical, responsive solutions in tax compliance, cross-border tax, global mobility, and transfer pricing. Headquartered in Germany with a presence in Austria, L+C advises large multinationals and family-owned companies, family offices, foundations, and high-net-worth individuals. The firm, founded in 2001, specializes in areas such as global mobility, M&A, international tax law, country-by-country reporting, and transfer pricing, including Pillar 2 reporting. Additionally, L+C supports clients with trusts and foundations, tax compliance, payroll and financial accounting, and private financial advisory services. “Collaborating with Andersen Global represents an important step in expanding our international capabilities and strengthening the value we provide to clients navigating increasingly complex cross-border matters,” said Jörg-Andre

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye